Aug 20, 2024 | Defective Drugs, Defective Medical Device, Defective Product, Product Liability, Tepezza Injuries
Tepezza (teprotumumab-trbw) is a breakthrough medication used to treat thyroid eye disease (TED), a rare condition that causes inflammation and bulging of the eyes. Tepezza was approved by the U.S. Food and Drug Administration (FDA) in January 2020 and has been...
Aug 6, 2024 | Defective Drugs, Defective Product, Medical News, Product Liability
Tepezza (teprotumumab) has emerged as a groundbreaking treatment for Thyroid Eye Disease (TED), a condition that can cause bulging eyes, double vision, and other serious issues. While Tepezza has offered hope to many patients, it has also raised concerns due to...
Jul 25, 2024 | Defective Drugs, Defective Product, Medical News, Personal Injury, Product Liability
In recent years, Tepezza, a groundbreaking treatment for Thyroid Eye Disease (TED), has offered hope to many patients suffering from this debilitating condition. However, as its usage has increased, so too have reports of severe side effects, particularly those...
